Atlas Trials

Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy

Clinical trial NCT01501370 · WITHDRAWN

Trial details

NCT number
NCT01501370
Sponsor
Tiziana Marangon
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-01-01
Primary completion
2012-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.